LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 37 filers reported holding LUMOS PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $776,942 | -0.6% | 235,437 | -0.6% | 0.00% | – |
| Q2 2023 | $781,994 | -0.3% | 236,968 | 0.0% | 0.00% | – |
| Q1 2023 | $784,364 | -8.3% | 236,968 | 0.0% | 0.00% | – |
| Q4 2022 | $855,455 | -59.2% | 236,968 | +0.0% | 0.00% | – |
| Q3 2022 | $2,097,000 | +15.0% | 236,915 | 0.0% | 0.00% | – |
| Q2 2022 | $1,824,000 | -18.5% | 236,915 | -0.5% | 0.00% | – |
| Q1 2022 | $2,238,000 | +35.6% | 238,108 | 0.0% | 0.00% | – |
| Q4 2021 | $1,650,000 | -27.4% | 238,108 | -0.4% | 0.00% | – |
| Q3 2021 | $2,274,000 | -4.4% | 239,029 | +0.5% | 0.00% | – |
| Q2 2021 | $2,379,000 | -14.5% | 237,898 | -0.0% | 0.00% | – |
| Q1 2021 | $2,784,000 | -65.7% | 237,953 | +4.6% | 0.00% | – |
| Q4 2020 | $8,122,000 | +165.3% | 227,464 | +2.7% | 0.00% | – |
| Q3 2020 | $3,062,000 | -17.6% | 221,547 | -1.7% | 0.00% | – |
| Q2 2020 | $3,717,000 | +201.9% | 225,391 | +55.7% | 0.00% | – |
| Q1 2020 | $1,231,000 | – | 144,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 153,867 | $507,761 | 0.30% |
| Lion Point Capital, LP | 78,351 | $258,558 | 0.12% |
| Minerva Advisors LLC | 26,549 | $84 | 0.06% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 31,088 | $102,591 | 0.02% |
| Greenwich Wealth Management LLC | 49,002 | $162 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |